Tilray | TRLY - 贸易债权人

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.3B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	贸易债权人	更改		日
Acasti Pharma	USD 459K		881K	2025-09
Akebia Therapeutics	USD 8.39M		12.8M	2026-03
Alaunos Therapeutics	USD 400K		213K	2026-03
Aurora Cannabis	CAD 68.03M		18.68M	2025-12
Avita Medical	AUD 8.96M		1.69M	2025-12
Canopy Growth	CAD 19.96M		1.83M	2025-12
Cronos Group	USD 10.28M		1.36M	2026-03
Dianthus Therapeutics	USD 5.27M		4.45M	2026-03
Divis Laboratories Ltd	INR 12.11B		1.71B	2026-03
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
IQVIA Holdings	USD 3.64B		112M	2026-03
Knight Therapeutics	CAD 125.76M		7.63M	2025-12
Moderna	USD 161M		156M	2026-03
Organigram Holdings	CAD 71.08M		18.17M	2025-12
Organon & Co	USD 983M		31M	2026-03
Revvity	USD 169.68M		15.78M	2026-03
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Tilray	USD 114.5M		3.69M	2025-09
Viatris	USD 1.2B		93.9M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03
Zealand Pharma A/S	346.6M		102.71M	2025-12